Raymond James Financial Inc. Makes New $1.94 Million Investment in Semler Scientific, Inc. (NASDAQ:SMLR)

Raymond James Financial Inc. acquired a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 35,900 shares of the company's stock, valued at approximately $1,939,000. Raymond James Financial Inc. owned about 0.39% of Semler Scientific as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC raised its stake in Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after acquiring an additional 500 shares in the last quarter. Sanctuary Advisors LLC increased its position in shares of Semler Scientific by 13.2% during the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after purchasing an additional 584 shares in the last quarter. Jones Financial Companies Lllp purchased a new stake in shares of Semler Scientific in the 4th quarter valued at about $34,000. State Street Corp grew its stake in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company's stock worth $2,784,000 after buying an additional 725 shares during the last quarter. Finally, IFP Advisors Inc acquired a new position in Semler Scientific during the fourth quarter worth approximately $54,000. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Stock Performance

NASDAQ SMLR traded down $0.21 during trading on Friday, reaching $33.85. The company's stock had a trading volume of 409,786 shares, compared to its average volume of 391,644. Semler Scientific, Inc. has a twelve month low of $20.88 and a twelve month high of $81.56. The firm has a market cap of $324.86 million, a price-to-earnings ratio of 6.89 and a beta of 1.29. The business's fifty day moving average price is $42.85 and its 200-day moving average price is $45.13.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $12.41 million during the quarter.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.